MYC and B-cell non-Hodgkin lymphoma: Indeed, c-Myc directly activates miR-21 transcription, and miR-21 targets Mxd1 to enhance c-Myc transcriptional activity, leading to sustained high levels of miR-21 and c-Myc in aggressive B cell lymphoma (Figure 6A).